News Archive

Sept. 2023 Specialty Drug List Now Available

A drug must meet all four of the rule criteria to be considered for inclusion on the HHSC specialty drug list (SDL). The SDL includes drugs MCOs may exclusively provide through their specialty pharmacy network.

Synagis Prior Authorization Begins Oct. 2 For Lower South Texas

Deadline for Draft Policy Review Due Oct. 5

HHSC To Implement Clinical Prior Authorizations For Fee-For-Service on Oct. 31

July 2023 Preferred Drug List Revised Aug. 30

Summary of July 2023 Drug Utilization Review Board Meeting Now Available

The Texas Drug Utilization Review Board met recently to make recommendations about clinical prior authorizations.

Agenda Available for Upcoming July Drug Utilization Review Board Meeting

Agenda items are now available for the next quarterly meeting of the Texas Drug Utilization Review Board.

MCO Search Now Available

Removal of Quantity Limits for Hepatitis C Medications, Including Mavyret Preferred Hepatitis C Treatment

HHSC Updated Clinical Prior Authorizations Criteria Guides